Biggest changeThe following table presents information about our common stock repurchases made during the year ended December 31, 2024 in accordance with our repurchase program (dollars in thousands, except per share amounts): Total Number of Shares Purchased Average Price Paid per Share (1) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares that may yet be Purchased under the Plans or Programs January 2, 2024 - January 31, 2024 75,138 $ 9.86 75,138 $ 9,087,747 January 17, 2024 (2) 100,000 21.57 100,000 6,932,747 February 1, 2024 - February 29, 2024 52,195 10.14 52,195 6,404,704 March 1, 2024 - March 28, 2024 67,494 11.84 67,494 5,607,039 April 1, 2024 - April 30, 2024 52,812 13.83 52,812 4,877,655 May 1, 2024 - May 31, 2024 39,994 13.37 39,994 4,343,681 June 3, 2024 - June 28, 2024 22,652 12.80 22,652 4,054,292 July 1, 2024 - July 31, 2024 24,936 13.73 24,936 3,712,310 August 1, 2024 - August 30, 2024 47,682 15.52 47,682 2,973,466 September 3, 2024 - September 30, 2024 41,340 15.53 41,340 2,332,294 October 1, 2024 - October 31, 2024 47,846 15.51 47,846 1,591,322 November 1, 2024 - November 29, 2024 59,354 16.44 59,354 5,616,804 December 2, 2024 - December 31, 2024 48,013 17.05 48,013 4,799,117 (Back to Index) 42 (Back to Index) (1) The average price paid per share as reflected above includes broker fees and commissions.
Biggest changeThe following table presents information about our common stock repurchases made during the year ended December 31, 2025 in accordance with our repurchase program (dollars in thousands, except per share amounts): Total Number of Shares Purchased Average Price Paid per Share (1) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares that may yet be Purchased under the Plans or Programs January 2, 2025 - January 31, 2025 44,306 $ 17.38 44,306 $ 4,030 February 3, 2025 - February 28, 2025 72,858 19.31 72,858 2,624 March 3, 2025 - March 31, 2025 103,024 21.35 103,024 426 April 1, 2025 - April 30, 2025 19,622 21.70 19,622 - May 1, 2025 - May 30, 2025 111,192 18.88 111,192 7,903 June 2, 2025 - June 30, 2025 140,747 18.10 140,747 5,359 July 1, 2025 - July 31, 2025 106,874 18.10 106,874 3,427 August 1, 2025 - August 29, 2025 6,290 20.79 6,290 3,296 September 2, 2025 - September 30, 2025 39,930 21.10 39,930 2,454 October 1, 2025 - October 31, 2025 88,359 20.23 88,359 8,169 November 3, 2025 - November 28, 2025 404,281 20.20 404,281 12 December 1, 2025 - December 31, 2025 450 23.97 450 - (1) The average price paid per share as reflected above includes broker fees and commissions.
NOL can generally be carried forward to offset both ordinary taxable income and capital gains in future years. The Tax Cuts and Jobs Act (“TCJA”) along with revisions made by the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act reduced the deduction for NOLs to 80% of taxable income and granted an indefinite carryforward period.
NOLs can generally be carried forward to offset both ordinary taxable income and capital gains in future years. The Tax Cuts and Jobs Act (“TCJA”) along with revisions made by the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act reduced the deduction for NOLs to 80% of taxable income and granted an indefinite carryforward period.
Our 8.625% Fixed-to-Floating Series C Cumulative Redeemable Preferred Stock, or Series C Preferred Stock, is listed on the NYSE and trades under the symbol “ACRPrC.” We have declared and paid dividends through January 2025. No dividends are currently in arrears on the Series C Preferred Stock.
Our 8.625% Fixed-to-Floating Series C Cumulative Redeemable Preferred Stock, or Series C Preferred Stock, is listed on the NYSE and trades under the symbol “ACRPrC.” We have declared and paid dividends through January 2026. No dividends are currently in arrears on the Series C Preferred Stock.
The graph and table assume that $100 was invested in each of our common stock, the Russell 2000 Index and the FTSE NAREIT All REIT Index on December 31, 2019, and that all dividends were reinvested. This data is furnished by the Research Data Group.
The graph and table assume that $100 was invested in each of our common stock, the Russell 2000 Index and the FTSE NAREIT All REIT Index on December 31, 2020, and that all dividends were reinvested. This data is furnished by the Research Data Group.
We have declared and paid dividends through January 2025. No dividends are currently in arrears on the Series D Preferred Stock. Issuer Purchases of Equity Securities In March 2016, our Board approved a securities repurchase program.
We have declared and paid dividends through January 2026. No dividends are currently in arrears on the Series D Preferred Stock. Issuer Purchases of Equity Securities In March 2016, our Board approved a securities repurchase program.
The following table summarizes our current and estimated tax loss carryforwards (dollars in millions): Tax Year Recognized REIT (QRS) Tax Loss Carryforwards TRS Tax Loss Carryforwards Tax Asset Item Operating Capital Operating Capital Net Operating Loss Carryforwards: Cumulative as of 2023 2023 Return $ 32.1 $ — $ 60.9 $ — Net Capital Loss Carryforwards: Cumulative as of 2023 2023 Return — 121.9 — 1.0 Total tax asset estimates $ 32.1 $ 121.9 $ 60.9 $ 1.0 Useful life Unlimited 5 years Various 5 years At December 31, 2024, we had $32.1 million of cumulative NOL to carry forward to future years.
The following table summarizes our current and estimated tax loss carryforwards (dollars in millions): Tax Year Recognized REIT (QRS) Tax Loss Carryforwards TRS Tax Loss Carryforwards Tax Asset Item Operating Capital Operating Capital Net Operating Loss Carryforwards: Cumulative as of 2024 2024 Return $ 32.1 $ — $ 62.0 $ — Net Capital Loss Carryforwards: Cumulative as of 2024 2024 Return — 115.9 — 20.8 Total tax asset estimates $ 32.1 $ 115.9 $ 62.0 $ 20.8 Useful life Unlimited 5 years Various 5 years At December 31, 2025, we had $32.1 million of cumulative NOL to carry forward to future years.
Manager Incentive Plan at December 31, 2024: (a) (b) (c) Plan Category Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans Excluding Securities Reflected in Column (a) Equity compensation approved by security holders: Restricted stock (1) 574,538 N/A Equity compensation plans not approved by security holders N/A N/A Total 574,538 700,822 (1) All restricted stock awards consist of unvested shares.
Manager Incentive Plan at December 31, 2025: (a) (b) (c) Plan Category Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans Excluding Securities Reflected in Column (a) Equity compensation approved by security holders: Restricted stock (1) 328,586 N/A Equity compensation plans not approved by security holders N/A N/A Total 328,586 700,822 (Back to Index) 40 (Back to Index) (1) All restricted stock awards consist of unvested shares.
In November 2021, our Board authorized and approved the continued use of our existing share repurchase program to repurchase an additional $20.0 million of our outstanding common stock. In November 2023, our Board authorized and approved the repurchase of an additional $10.0 million of outstanding shares of both common and preferred stock.
In November 2021, our Board authorized and approved the continued use of our existing share repurchase program to repurchase an additional $20.0 million of our outstanding common stock. From November 2023 through October 2025, our Board authorized and approved the repurchase of an additional $32.5 million of outstanding shares of both common and preferred stock.
Additionally, we have cumulative total net capital losses of $121.9 million, which are set to expire on December 31, 2025. We also have tax assets in our taxable REIT subsidiaries (“TRS”). These tax assets are analyzed and disclosed quarterly in our financial statements.
Additionally, we have cumulative total net capital losses of $115.9 million, which expired on December 31, 2025, if not utilized on our tax return to be filed in October 2026. We also have tax assets in our taxable REIT subsidiaries (“TRS”). These tax assets are analyzed and disclosed quarterly in our financial statements.
(Back to Index) 41 (Back to Index) The following table summarizes certain information about our 2005 Stock Incentive Plan, Third Amended and Restated Omnibus Equity Compensation Plan and ACRES Commercial Realty Corp.
Such information was obtained through our registrar and transfer agent. The following table summarizes certain information about our 2005 Stock Incentive Plan, Third Amended and Restated Omnibus Equity Compensation Plan and ACRES Commercial Realty Corp.
(2) These repurchases pertain to our Series D Cumulative Preferred Stock. All other repurchases listed pertain to our common stock. Performance Graph The following line graph presentation compares cumulative total shareholder returns on our common stock with the Russell 2000 Index and the FTSE NAREIT All REIT Index for the period from December 31, 2019 to December 31, 2024.
(Back to Index) 41 (Back to Index) Performance Graph The following line graph presentation compares cumulative total shareholder returns on our common stock with the Russell 2000 Index and the FTSE NAREIT All REIT Index for the period from December 31, 2020 to December 31, 2025.
We are organized and conduct our operations to qualify as a real estate investment trust (“REIT”) which requires that we distribute at least 90% of our REIT taxable income.
We are organized and conduct our operations to qualify as a real estate investment trust (“REIT”) which requires that we distribute at least 90% of our REIT taxable income. During the year ended December 31, 2025, all taxable income was distributed to our preferred shareholders, and therefore, no common share distribution was required.
The 180 holders of record include Cede & Co., which holds shares as nominee for The Depository Trust Company, which itself holds shares on behalf of the beneficial owners of our common stock. Such information was obtained through our registrar and transfer agent.
At March 6, 2026, there were 7,131,101 shares of common stock outstanding held by 180 holders of record. The 180 holders of record include Cede & Co., which holds shares as nominee for The Depository Trust Company, which itself holds shares on behalf of the beneficial owners of our common stock.
At December 31, 2024, our TRS had $60.9 million of NOLs comprising: $39.8 million of pre-TCJA NOLs, some of which are set to expire beginning in 2044 and $21.1 million of NOLs with an indefinite carryforward period. At March 13, 2025, there were 7,456,150 shares of common stock outstanding held by 180 holders of record.
At December 31, 2025, our TRS had $62.0 million of NOLs comprising: $39.8 million of pre-TCJA NOLs, some of which are set to expire beginning in 2044 and $22.2 million of NOLs with an indefinite carryforward period. We also have $20.8 million of CLCFs from prior years, which are set to expire on December 31, 2029.
As we continue to take steps necessary to stabilize our earnings available for distribution ("EAD"), our board of directors, (our "Board"), will establish a plan for the prudent resumption of the payment of common share distributions.
Our board of directors, (our "Board"), is responsible for the establishment and evaluation of a plan for the prudent resumption of the payment of common share distributions.